The below offer is brought to you by our sponsor, Legend Research Edward, The economic state of affairs around the globe and a vaccine for the coronavirus are all very uncertain. However, there's one thing I know for a fact - your desire for wealth has never and will never fade; that my friend is a certainty, dreams never die. Last year I was on the right side of 12 FDA approvals for 10 takeovers pocketing countless millions. So far this year, I have been on a rampage heading over 7 FDA approvals in the first few months of the year. My soon to be new value client, put your mind and heart at ease. There is one certainty on Wall Street when you position yourself into a stock well before the masses have any idea of an FDA approval; you can rest assured no matter what's happening in the world this stock has the best chance to work and even possibly will make a huge run. I put millions into the pockets of the investors that had the foresight to position themselves long before the news hits the street. Not only do you stand the chance of possibly making more money than you've ever made in your life, you can become legendary. So here it is my gift to you absolutely FREE, the 2020 Legend Research legendary FDA approval of a lifetime; a trade so powerful it can only be considered the single most profitable trade you will ever place in your account. Click this link now and I will hand-deliver you this life-changing opportunity for FREE. Sincerely, Legend Research | To accept this special invitation, click here. | U.S. STOCK INDEXES GENERAL STOCK MARKET COMMENT: U.S. stock indexes closed firmer today. Global stock markets were mixed overnight. It now appears less likely the U.S. Congress and the Trump administration can come to agreement on a new Covid-19 stimulus package before the U.S. elections in less than two weeks. All sides are still in communication regarding getting some kind of a stimulus package for Americans, however. The U.S. Senate Republicans could stymie any deal that is agreed upon by the House and the Trump administration. Corporate earnings reports are also in focus at present. Rising Covid-19 cases in the U.S., Europe and South America continue to dampen trader and investor enthusiasm at mid-week. Drug makers are rushing for a successful vaccine, but none appear ready for public consumption any time soon. In other news, China recently eased its rules on banks trading in the China currency, the yuan, allowing the currency to strengthen. Reports say China is promoting the yuan as the new world reserve currency. The yuan today rose nearly 0.5% to its strongest level against the U.S. dollar since July of 2018. China continues to recover more rapidly from Covid-19 as the U.S. and Europe see rising cases. The Yuan has strengthened more than 7% against the greenback since late May. "In addition to dollar weakness, the yuan is being underpinned by a wide interest-rate premium over the rest of the world. China's 10-year government bond yields are around 3.2% as the gap versus the yield on U.S. Treasuries hovers around the highest on record," said an SP Angel email dispatch this morning. The important outside markets early today saw the U.S. dollar index lower again and hitting a six-week low. Nymex crude oil prices were lower and trading around $40.00 a barrel. The yield on the benchmark U.S. 10-year Treasury note is 0.8% today.
U.S. Government Required Disclaimer - Commodity Futures Trading Commission Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown. All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results. Each individual's success depends on his or her background, dedication, desire, and motivation. | |
Wealthy Retirement ...
-
insidecroydon posted: " Become a Patron! What's on inside Croydon: Click here for the latest events listing...
-
-
|
No comments:
Post a Comment